Immunosuppressive effects of ovalicin-semicarbazone.
D000818:Animals; D006224:Cricetinae; D003510:Cyclohexanes / Q000494:pharmacology*; D003512:Cyclohexanones / Q000494:pharmacology*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy; D004852:Epoxy Compounds / Q000494:pharmacology; D005260:Female; D006084:Graft Rejection / Q000187:drug effects; D006168:Guinea Pigs; D006384:Hemagglutination / Q000187:drug effects; D006462:Hemolytic Plaque Technique; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008815:Mice, Inbred Strains; D009929:Organ Size; D051381:Rats; D012664:Semicarbazones / Q000494:pharmacology; D012717:Sesquiterpenes; D014374:Tuberculin Test
D003510:Cyclohexanes; D003512:Cyclohexanones; D004852:Epoxy Compounds; D007166:Immunosuppressive Agents; D012664:Semicarbazones; D012717:Sesquiterpenes; C002781:ovalicin